Older patients with atrial fibrillation (AF) are at higher risk of thromboembolic events and oral
anticoagulant (OAC)-related bleeding complications. This meta-analysis evaluates the …

Background: Direct oral anticoagulants (DOACs) have been widely used in patients with
atrial fibrillation (AF) for antithrombotic prophylaxis, which were shown to have a favorable …

Elderly patients with atrial fibrillation are at a higher risk of both ischemic and bleeding
events compared with younger patients; therefore, balancing risks and benefits of …

Background and objective the study analysed the effectiveness and safety of warfarin use
compared with warfarin non-use and non-vitamin K antagonist oral anticoagulants (NOACs) …

Background Oral anticoagulation (OAC) is effective in stroke prevention in elderly patients
with nonvalvular atrial fibrillation (AF), but older patients are also at higher risk of bleeding …

Direct oral anticoagulants (DOACs) have shown similar efficacy and safety with respect to
warfarin in patients with atrial fibrillation (AF). However, the proportion of patients aged≥ 85 …

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and its prevalence
increases with age. Few data are available about the clinical performance of direct oral …

Background: Stroke prevention with oral anticoagulants (OACs) is the cornerstone for the
management of atrial fibrillation (AF). However, data about the use of OACs among …

Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …

Older people, are underrepresented in randomised controlled trials of direct oral
anticoagulants (DOACs) for stroke prevention in atrial fibrillation (AF). The aim of this study …